Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 5
1996 5
1997 7
1998 10
1999 8
2000 11
2001 10
2002 8
2003 11
2004 13
2005 13
2006 8
2007 9
2008 9
2009 5
2010 4
2011 7
2012 8
2013 7
2014 5
2015 8
2016 8
2017 5
2018 9
2019 4
2020 7
2021 4
2022 11
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P, Mellemkjaer L, Bernstein L, Tellhed L, Xue S, Olson ER, Liang X, Dolle J, Børresen-Dale AL, Bernstein JL. Borg A, et al. Among authors: mellemkjaer l. Hum Mutat. 2010 Mar;31(3):E1200-40. doi: 10.1002/humu.21202. Hum Mutat. 2010. PMID: 20104584 Free PMC article.
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.
Pedersen RN, Esen BÖ, Mellemkjær L, Christiansen P, Ejlertsen B, Lash TL, Nørgaard M, Cronin-Fenton D. Pedersen RN, et al. Among authors: mellemkjaer l. J Natl Cancer Inst. 2022 Mar 8;114(3):391-399. doi: 10.1093/jnci/djab202. J Natl Cancer Inst. 2022. PMID: 34747484 Free PMC article.
Mortality After Late Breast Cancer Recurrence in Denmark.
Pedersen RN, Mellemkjær L, Ejlertsen B, Nørgaard M, Cronin-Fenton DP. Pedersen RN, et al. Among authors: mellemkjaer l. J Clin Oncol. 2022 May 1;40(13):1450-1463. doi: 10.1200/JCO.21.02062. Epub 2022 Feb 16. J Clin Oncol. 2022. PMID: 35171656
Nonaspirin NSAIDs and contralateral breast cancer risk.
Bens A, Cronin-Fenton D, Dehlendorff C, Jensen MB, Ejlertsen B, Kroman N, Friis S, Mellemkjaer L. Bens A, et al. Among authors: mellemkjaer l. Int J Cancer. 2019 Mar 15;144(6):1243-1250. doi: 10.1002/ijc.31949. Epub 2018 Dec 6. Int J Cancer. 2019. PMID: 30362513 Free article.
Use of beta-blockers and risk of contralateral breast cancer.
Gottschau M, Bens A, Friis S, Cronin-Fenton D, Aalborg GL, Jensen MB, Ejlertsen B, Kroman N, Mellemkjaer L. Gottschau M, et al. Among authors: mellemkjaer l. Int J Cancer. 2022 May 15;150(10):1619-1626. doi: 10.1002/ijc.33923. Epub 2022 Jan 25. Int J Cancer. 2022. PMID: 34985760 Free article.
Survival in Women Diagnosed With Breast Cancer During Pregnancy.
Viuff JH, Greiber IK, Karlsen MA, Storgaard L, Kroman N, Jensen MB, Eibye S, Hjortshøj CS, Ejlertsen B, Winther JF, Kjær SK, Mellemkjær L. Viuff JH, et al. Among authors: mellemkjaer l. Clin Breast Cancer. 2022 Jun;22(4):e517-e525. doi: 10.1016/j.clbc.2021.11.009. Epub 2021 Dec 1. Clin Breast Cancer. 2022. PMID: 34963614
Mortality after contralateral breast cancer in Denmark.
Langballe R, Frederiksen K, Jensen MB, Andersson M, Cronin-Fenton D, Ejlertsen B, Mellemkjær L. Langballe R, et al. Among authors: mellemkjaer l. Breast Cancer Res Treat. 2018 Sep;171(2):489-499. doi: 10.1007/s10549-018-4846-3. Epub 2018 Jun 11. Breast Cancer Res Treat. 2018. PMID: 29948403
215 results